In a good-news-bad-news week for Biogen, the company will cut an undisclosed number of employees, just as a higher dose of ...

In reality, class oppression is inherent to the state itself. We can see this in the subordination of workers in the public sector to a top-down corporate-style managerial bureaucracy — teachers ...

This causes the viral RNA to be transcribed into DNA, hence stopping the virus from incorporating its DNA into the host DNA and thus multiplying through host cell machinery ... New Drug Application, ...

More than a billion years ago a hungry cell devoured a tiny blue-green alga. But instead of the former simply digesting the latter, the duo struck a remarkable evolutionary deal. Now scientists ...

Deere & Co is strengthening its bet on autonomous machinery, unveiling new tractors and industrial equipment capable of operating without the need for a human being in the cab. At the annual ...

Welireg's sNDA for advanced PPGL treatment is under FDA priority review, potentially becoming the first U.S. therapy for this condition. The LITESPARK-015 trial supports the sNDA with ORR and DOR data ...

Merck MRK announced that the FDA has accepted its supplemental new drug application (sNDA) seeking approval of its oral HIF-2α inhibitor, Welireg (belzutifan), for a new indication. The sNDA is ...

Scilex (SCLX) announced that it will be filing today of a Supplemental New Drug Application, SNDA, with the FDA for ELYXYB in acute pain indication. “We are well positioned to broaden the ELYXYB ...

At Sonida Senior Living, a filing with the SEC revealed that on Friday, Michael Simanovsky bought 42,111 shares of SNDA, at a cost of $21.32 each, for a total investment of $897,835. So far ...

(RTTNews) - Johnson & Johnson (JNJ), Tuesday announced that the U.S. Food and Drug Administration has approved supplemental New Drug Application or sNDA for Spravato, a monotherapy for adults with ...